Isabel P. Neuringer

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry Heijerman, Edward F. McKone, D.G. Downey et al. · The Lancet · 2019 · 1.3K citations · Full text

Mendelian Disorder, Genetics, Ivacaftor Combination Regimen +2

Severe Osteoporosis Before and After Lung Transplantation

R M Aris, Isabel P. Neuringer, Meredith Weiner et al. · CHEST Journal · 1996 · 266 citations

Bone Disease, Transplantation Surgery, Transplantation +7

Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation

Leonard J. Lobo, Robert M. Aris, John L. Schmitz et al. · The Journal of Heart and Lung Transplantation · 2012 · 154 citations · Full text

Transplant Rejection, Lung Transplantation, Acute Cellular Rejection +11

Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient.

R M Aris, Diane M. Maia, Isabel P. Neuringer et al. · American Journal of Respiratory and Critical Care Medicine · 1996 · 152 citations

Lung Transplantation, Post-transplantation Lymphoproliferative Disorder, Immunodeficiencies +17

Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease

Siddhartha G. Kapnadak, Emily DiMango, Denis Hadjiliadis et al. · Journal of Cystic Fibrosis · 2020 · 148 citations · Full text